Search the Newsreel

Alphabet Counts the Ka-Ching With SpaceX Returns

Alphabet Counts the Ka-Ching With SpaceX Returns - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. In 2015, Google …

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

Alphabet Is Berkshire Hathaway’s New Favorite Stock After Buying 48 Million Shares

Quick Read Greg Abel broke Berkshire's 14-quarter net-selling streak by buying 48 million Alphabet shares worth $37.8 billion in Q2. The purchase vaults Alphabet to Berkshire's third-largest holding at 10% of the portfolio, behind only Apple and American Express. Alphabet's search monopoly, 2.7 billion …

UpHealth Group H1 2026 Results: Post-Acquisition Revenue of S$29.96M, Net Loss Widens to S$4.79M, No Interim Dividend Declared – Minichart

Alphabet vs. Oracle: Which Is the Better AI Stock to Own for the Next 5 Years?

Cloud computing has become ground zero for artificial intelligence (AI) development. The large cloud infrastructure companies provide platforms where developers can create their AI apps, which is where the magic happens. Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Oracle (NYSE: ORCL) are the third- and …

Technical Reactions to AVBP Trends in Macro Strategies

This article provides a technical analysis of Arrivent Biopharma Inc. (NASDAQ: AVBP) trends, highlighting neutral near and mid-term readings but a potentially strong long-term positive bias. It details institutional trading strategies, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The …

Summit Global Investments Acquires Shares of 7,182 Vertex Pharmaceuticals Incorporated $VRTX

Summit Global Investments purchased 7,182 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in the second quarter, valued at approximately $3.57 million. Other hedge funds also adjusted their holdings, with institutional investors now owning 90.96% of the stock. Analysts currently have a "Moderate Buy" rating for VRTX …

Oppenheimer Asset Management Inc. Decreases Stock Holdings in Philip Morris International Inc. $PM

Oppenheimer Asset Management Inc. reduced its stake in Philip Morris International Inc. by 4.1% in the second quarter of 2026, selling 8,337 shares and retaining 194,006 shares valued at $35.1 million. Despite this, Philip Morris reported strong quarterly results with revenue of $11.19 billion …

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

Alpha & Omega Semiconductor : AOSL

This article provides an overview of Alpha & Omega Semiconductor Ltd (AOSL), a company specializing in advanced semiconductor products for various devices, from smartphones to electric vehicles. It highlights AOSL's product portfolio, including power discrete products, power ICs, and silicon carbide solutions, and mentions …

Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock

An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. The investigation focuses on whether Theravance's board failed to secure the best possible price, conducted a fair sales process, …

Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP

Walleye Capital LLC has acquired a new position in ANI Pharmaceuticals, purchasing 106,112 shares valued at approximately $8.8 million, indicating growing institutional interest as hedge funds and other investors collectively own 76.05% of the company. ANI Pharmaceuticals recently surpassed quarterly earnings expectations, reporting adjusted …

Spyglass Pharma (NASDAQ:SGP) Upgraded to "Moderate Buy" at Raymond James Financial

Sundar Pichai's Alphabet Reported Negative Free Cash Flow for the First Time Ever. Here's Why That Milestone Matters for Shareholders.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) shares have crushed the market in the past 10 years. They have produced a total return of 759% since August 2016 (as of Aug. 13). Given that incredible past performance, investors might be inclined to always give this business …

Trifecta Capital Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX

Trifecta Capital Advisors LLC has acquired a new position in Vertex Pharmaceuticals (NASDAQ:VRTX), purchasing 16,745 shares valued at approximately $8.318 million, making it their 27th largest holding. Other institutional investors like Capital Research Global Investors and State Street Corp also increased their stakes. This …

Oppenheimer Asset Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Oppenheimer Asset Management Inc. has acquired a new stake of 17,931 shares in Vertex Pharmaceuticals (NASDAQ:VRTX), valued at approximately $8.91 million during the second quarter. This new investment comes as other institutional investors have also adjusted their holdings in VRTX. Vertex Pharmaceuticals reported earnings …

Jennison Associates LLC Has $4.95 Billion Stock Position in Alphabet Inc. $GOOG

Laser Photonics Reports Second Quarter 2026 Financial Results

Laser Photonics Corporation reported its second-quarter 2026 financial results, showing a near doubling of net sales sequentially to $1.8 million and a return to positive gross margin at 8.4%. The company also highlighted significant advancements in its Laser Shield Anti-Drone System with U.S. government …

86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC

Walleye Capital LLC has acquired 86,249 shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) during the second quarter, valued at approximately $3.12 million, representing a 0.31% stake in the company. This acquisition comes as Eton Pharmaceuticals reported strong quarterly results, exceeding revenue and EPS expectations, and …

Quantinno Capital Management LP Buys 24,878 Shares of Crinetics Pharmaceuticals, Inc. $CRNX

Quantinno Capital Management LP significantly increased its stake in Crinetics Pharmaceuticals, Inc. (CRNX) by 280.9% in Q1, acquiring an additional 24,878 shares to reach a total of 33,734 shares valued at $1.225 million. This comes as Crinetics Pharmaceuticals reported strong Q1 revenues of $25.12 …

California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN

The California State Teachers Retirement System significantly increased its holdings in Urogen Pharma (NASDAQ:URGN) by 1,605.5% in the first quarter, now owning 38,750 shares valued at $697,000. Institutional investors collectively hold 91.29% of the company, which has an average analyst rating of "Moderate Buy" …

Vontobel Holding Ltd. Sells 327,807 Shares of Philip Morris International Inc. $PM

Vontobel Holding Ltd. significantly reduced its stake in Philip Morris International Inc. by selling 327,807 shares, though it still retains a substantial holding worth $137.2 million. The article notes that institutional investors collectively own 78.63% of the company, and analysts maintain a "Moderate Buy" …

How Investors May Respond To ANI Pharmaceuticals (ANIP) Record Q2 Results And Reaffirmed 2026 Revenue Guidance

Crinetics Pharmaceuticals (CRNX) Reports Q2 2026 Results, Is The Stock About Right?

ARS Pharmaceuticals (SPRY) Stock Faces Margin Squeeze As Losses Deepen

Walleye Capital LLC Invests $4.84 Million in Xeris Biopharma Holdings, Inc. $XERS

Walleye Capital LLC has invested $4.84 million in Xeris Biopharma Holdings, Inc. by acquiring 611,296 shares in the second quarter, representing 0.35% of the company. Institutional investors collectively own 42.75% of Xeris. Despite reporting higher-than-expected revenue of $92.1 million, the company posted an adjusted …

Walleye Capital LLC Buys New Position in Xenon Pharmaceuticals Inc. $XENE

Walleye Capital LLC has acquired a new position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE), purchasing 76,955 shares valued at approximately $4.65 million. This move is amidst positive analyst sentiment with a "Buy" rating and a $77.13 average price target, despite recent insider stock sales totaling …

Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress

Amylyx Pharmaceuticals (AMLX) stock has seen a 170.4% return over the past year, but its valuation metrics suggest it is trading at a premium. The progress of the avexitide trial, including its completed pivotal trial and potential commercial launch, supports future cash flow expectations, …

Redcare Pharmacy Aktie • A2AR94 • NL0012044747

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands

Madrigal Pharmaceuticals' drug Rezdiffra achieved a $1.3 billion trailing-12-month revenue run rate in Q2 2026, with revenue up 71% year-over-year and over 49,000 active patients. The company is expanding its MASH pipeline to 10 assets, primarily for combination with Rezdiffra, targeting weight loss, liver-fat …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Royal Bank of Canada Boosts Holdings in Triumph Financial, Inc. $TFIN

Fire Capital Management LLC Boosts Stock Position in Alphabet Inc. $GOOG

Fire Capital Management LLC significantly increased its stake in Alphabet Inc. ($GOOG) by 137.3% in the second quarter, bringing its total holdings to 8,648 shares valued at $3.06 million. Despite some negative sentiment regarding AI investment costs and competitive pressures, institutional investors collectively own …